HLA DRB1* typing and cartilage oligomeric matrix protein as predictors of joint destruction in recent onset rheumatoid arthritis

Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35–54 years with chronic knee pain.

Cartilage matrix macromolecules in joint fluid of temporomandibular joints before and six months after diskectomy

The purpose was to investigate if antigenic fragments of aggrecan and cartilage oligomeric matrix protein (COMP) are detectable by enzyme-linked immunosorbent assay in lavage fluids from the temporomandibular joint (TMJ) and to examine if the relative content of these cartilage markers changes during development of osteoarthrosis (OA) after diskectomy. Lavage fluid was obtained at surgery and 6 mo

Storytelling as a tool of authentication in jazz discourse

Cartilage macromolecules and the development of new methods for the assessment of joint disease

Serum analyses of tissue derived macromolecules and markers of inflammation in early rheumatoid arthritis. Relation to development of joint destructions in hands and feet

SUMMARY We have previously shown that serum concentrations of cartilage oligomeric matrix protein (COMP) are increased early in rheumatoid arthritis (RA) patients who subsequently develop advanced large-joint destruction. A prognostic value for joint damage of serum concentrations of hyaluronan (HA) is also suggested by previous studies. In contrast, serum concentrations of bone sialoprotein (BSP)

Postero-anterior radiogram of the knee in weightbearing and semiflexion. Comparison with MR imaging

Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis

Cartilage macromolecules in knee synovial fluid. Markers of the disease course in patients with acute oligoarthritis

OBJECTIVE To investigate the development of chronic joint symptoms in patients presenting with acute oligoarthritis including knee joint synovitis with effusion and explore whether prognostic information can be derived from initial synovial fluid concentrations of aggrecan and cartilage oligomeric matrix protein (COMP) for development of chronic joint symptoms. METHODS Retrospective follow up of

Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint

Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis

Joint space width in the axial view of the patello-femoral joint: Definitions and comparisons with MR imaging

Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats

Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one year prospective study.

Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats

Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with osteoarthritis-related type II collagen gene COL2A1 mutation

Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis

Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978

The aim of this study was to evaluate differences in disease activity, disability, and medical treatment in consecutive patients with rheumatoid arthritis seen at the outpatient clinics in Malmö, in 1978 (n=148) and 1995 (n=164). The groups were similar with regard to age, gender, disease duration, and the proportion having had hip or knee replacement surgery. The patients in 1995 had lower values

Noncollagenous Proteins: Glycoproteins and Related Proteins

IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.